Global Organ Transplantation Market Overview:
Organ transplantation refers to the replacement of the diseased or damaged organ with a healthy organ. The organs may be donated by live donors or harvested from a brain dead organ donors. Organ dysfunction caused due to severe injuries cancer, organ failure and/or genetic disorders necessitates the requirement for organ transplant procedures. Some of the players profiled in the study are Bio Med Pvt. Ltd. (United States), Terumo Medical Corporation (United States), Preservation Solutions, Inc. (United States), Transonic (United States), Pfizer, Inc. (United States), TransMedic, Inc. (United States), GlaxoSmithKline Plc. (United Kingdom), OrganOX Limited (United Kingdom), Transplant Biomedical (United Kingdom), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland) and Accord Healthcare GmbH (Spain).
On the basis of geography, the market of Organ Transplantation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Organ Type, the sub-segment i.e. Heart will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End user, the sub-segment i.e. Hospitals will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Type of Transplant , the sub-segment i.e. Autograft will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Increasing Number of Chronic Diseases and Organ Failure
- Growing Consumption of Alcohol and Unhealthy Diet
- Increasing Relevance of Renal Diseases
- Technology Advancement and Innovation In Medical Sector
- Organ and Tissue Procurement And Its preservation
- High Cost of Transplantation
- Limited Number of Donors
- Increasing Incidences And Organ Failure
- Rising Aging Population and Changing Lifestyle
- Huge Gap Between Demand and Supply For Organ Transplantation
Key Market Developments:
Organs that have been successfully transplanted include the heart, kidneys, brain, liver, lungs, pancreas, intestine, and thymus. From the year 2000 and forward, there have been approximately 2,200 lung transplants performed each year worldwide. From between 2000 and 2006, the median survival period for lung transplant patients has been 5-and-a-half years, meaning half the patients survived for a shorter time period and a half survived for a longer period. In China, a kidney transplant operation runs for around USD 70,000, liver for USD 160,000, and heart for USD 120,000. Although these prices are still unattainable to the poor, compared to the fees of the United States, where a kidney transplant may demand USD 100,000, a liver USD 250,000, and a heart USD 860,000, Chinese prices have made China a major provider of organs and transplantation surgeries to other countries.
According to National Kidney Foundation “Around 3,000 new patients are added to the kidney waiting list each month worldwide.” According to the United Network for organ sharing, in the United States every day 21 people die to wait for an organ, and more than 120,000 men, women, and children await lifesaving organ transplants. and According to the Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among them about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017.
Ongoing awareness of developments in medical technologies is integral to understanding and utilizing the best options available. Development in the field of organ transplantation such as machine reperfusion of organs have the potential to transform and increase the opportunities for patients needing a transplant. Repair and regeneration of organs will have a substantial impact on the number of suitable organ donors. Both mechanical and biological (stem cell) organ replacement therapies may change the profile of people needing an organ transplant. Work with the eye and tissue banking sector will continue to foster a strong national network, and consistency and sustainability of the sector.
Pharmaceutical Companies, Research and Development (R&D) Companies, Independent Research Laboratories, Market Research and Consulting Service Providers, Medical Research Laboratories, Academic Medical Institutes and Universities and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Organ Transplantation market on the basis of product [Preservation Solutions, Transplant Diagnostics, Tissue Products and Others (Immunosuppressive drugs)] , application [Children, Adults and Senior Citizens], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Organ Transplantation market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Organ Transplantation industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Astellas Pharma, Inc (Japan) and Veloxis Pharmaceuticals A/S (Denmark).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Organ Transplantation market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.